BACKGROUND: Inflammatory bowel disease (IBD) is characterized by an injured epithelium. Development of agents that could enhance mucosal healing is a major goal in IBD therapeutics. The 18-kDa antrum mucosal protein (AMP-18) and a 21-mer peptide derived from AMP-18 stimulate accumulation of tight junction (TJ) proteins in cultured epithelial cells and mouse colonic mucosa to protect the mucosal barrier, suggesting it might be a useful agent to treat IBD. METHODS: We searched for molecular mechanisms by which AMP peptide or recombinant AMP-18 act on TJs in intact cell monolayers, or those disrupted by low-calcium medium. Roles of the p38 mitogen-activated protein kinase (MAPK) / heat shock protein (hsp)25 pathway and PKCζ were investigated by immunoblotting and confocal microscopy. RESULTS: AMP peptide activated p38 MAPK, which subsequently phosphorylated hsp25. Accumulated phospho-hsp25 was associated with perijunctional actin. AMP-18 also induced rapid phosphorylation of PKCζ and its colocalization with perijunctional actin in Caco2/bbe cells, which was accompanied by translocation and formation of complexes of "polarity proteins" in the TJ-containing detergent-insoluble fraction. Treatment with AMP-18 also stimulated accumulation of ZO-1, ZO-2, and JAM-A in nascent TJs known to associate with the multimeric p-PKCζ/Par6/ Cdc42/ECT2·GTP/Par3 polarity protein complex. CONCLUSIONS: AMP-18 facilitates translocation and assembly of multiple proteins into TJs and their association with and subsequent stabilization of the actin filament network. We speculate that improved barrier function induced by AMP-18 is mediated by enhanced TJ assembly. Thus, AMP-18 may provide a promising lead to develop agents effective in healing injured colonic epithelium in IBD.
BACKGROUND:Inflammatory bowel disease (IBD) is characterized by an injured epithelium. Development of agents that could enhance mucosal healing is a major goal in IBD therapeutics. The 18-kDa antrum mucosal protein (AMP-18) and a 21-mer peptide derived from AMP-18 stimulate accumulation of tight junction (TJ) proteins in cultured epithelial cells and mousecolonic mucosa to protect the mucosal barrier, suggesting it might be a useful agent to treat IBD. METHODS: We searched for molecular mechanisms by which AMP peptide or recombinant AMP-18 act on TJs in intact cell monolayers, or those disrupted by low-calcium medium. Roles of the p38 mitogen-activated protein kinase (MAPK) / heat shock protein (hsp)25 pathway and PKCζ were investigated by immunoblotting and confocal microscopy. RESULTS:AMP peptide activated p38 MAPK, which subsequently phosphorylated hsp25. Accumulated phospho-hsp25 was associated with perijunctional actin. AMP-18 also induced rapid phosphorylation of PKCζ and its colocalization with perijunctional actin in Caco2/bbe cells, which was accompanied by translocation and formation of complexes of "polarity proteins" in the TJ-containing detergent-insoluble fraction. Treatment with AMP-18 also stimulated accumulation of ZO-1, ZO-2, and JAM-A in nascent TJs known to associate with the multimeric p-PKCζ/Par6/ Cdc42/ECT2·GTP/Par3 polarity protein complex. CONCLUSIONS:AMP-18 facilitates translocation and assembly of multiple proteins into TJs and their association with and subsequent stabilization of the actin filament network. We speculate that improved barrier function induced by AMP-18 is mediated by enhanced TJ assembly. Thus, AMP-18 may provide a promising lead to develop agents effective in healing injured colonic epithelium in IBD.
Authors: T Yamanaka; Y Horikoshi; A Suzuki; Y Sugiyama; K Kitamura; R Maniwa; Y Nagai; A Yamashita; T Hirose; H Ishikawa; S Ohno Journal: Genes Cells Date: 2001-08 Impact factor: 1.891
Authors: Joe G N Garcia; Peiyi Wang; Kane L Schaphorst; Patrice M Becker; Talaibek Borbiev; Feng Liu; Anna Birukova; Keri Jacobs; Natalia Bogatcheva; Alexander D Verin Journal: FASEB J Date: 2002-07 Impact factor: 5.191
Authors: A Avila-Flores; E Rendón-Huerta; J Moreno; S Islas; A Betanzos; M Robles-Flores; L González-Mariscal Journal: Biochem J Date: 2001-12-01 Impact factor: 3.857
Authors: A Suzuki; T Yamanaka; T Hirose; N Manabe; K Mizuno; M Shimizu; K Akimoto; Y Izumi; T Ohnishi; S Ohno Journal: J Cell Biol Date: 2001-03-19 Impact factor: 10.539
Authors: Fabian B Fahlbusch; Matthias Ruebner; Hanna Huebner; Gudrun Volkert; Hannah Bartunik; Ilona Winterfeld; Andrea Hartner; Carlos Menendez-Castro; Stephanie C Noegel; Ines Marek; David Wachter; Regine Schneider-Stock; Matthias W Beckmann; Sven Kehl; Wolfgang Rascher Journal: Histochem Cell Biol Date: 2015-06-13 Impact factor: 4.304
Authors: Peili Chen; Danika Bakke; Lauren Kolodziej; James Lodolce; Christopher R Weber; David L Boone; F Gary Toback Journal: Inflamm Bowel Dis Date: 2015-10 Impact factor: 5.325
Authors: Peili Chen; Maria Mancini; Stephen T Sonis; Juan Fernandez-Martinez; Jing Liu; Ezra E W Cohen; F Gary Toback Journal: PLoS One Date: 2016-04-06 Impact factor: 3.240
Authors: Rocío López-Posadas; Michael Stürzl; Imke Atreya; Markus F Neurath; Nathalie Britzen-Laurent Journal: Front Immunol Date: 2017-10-05 Impact factor: 7.561